Delivery Order SPE2DB20D3103-SPE2DB25FQ4Y3
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lyrica 225 mg capsules (90-count) with a ceiling value of $1,218.19. This non-competitive, firm fixed-price delivery order was awarded on August 25, 2025, with an ultimate completion date of August 26, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Lyrica 100 mg capsules (90-count) with a ceiling value of $1,213.60. This firm fixed-price delivery order, with an ultimate completion date of August 13, 2025, represents a competitively awarded, non-set-aside contract. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,580.34 to AmerisourceBergen Drug Corp for the supply of Lyrica 100 mg capsules (90-count units). This firm fixed price, competitively awarded contract was issued on September 11, 2025, with an ultimate completion date of September 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified pharmaceutical...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 9, 2025, for the supply of Lyrica 100 mg capsules (90-count units) valued at $2,530.67. This firm fixed-price delivery order, which is set to be completed by September 10, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was awarded competitively with no set-aside designation, and the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lyrica 225 mg capsules (90-count units) under a firm fixed-price contract with a ceiling value of $2,383.48. The award, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a non-set-aside, competitively awarded delivery order. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as...
- The Defense Logistics Agency awarded a $7,159.80 delivery order to AmerisourceBergen Drug Corp for the supply of Lyrica 100 mg capsules (90-count units) under a firm fixed-price contract. The award was made on July 21, 2025, with an ultimate completion date of July 22, 2025, and represents a non-set-aside competitive award. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,100.28 for Lyrica 300 mg capsules (90-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Lyrica 100 mg capsules (90-count units) at a ceiling value of $1,260.77. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for ultimate completion by August 1, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lyrica 100 mg capsules (90-count units) under a firm fixed-price contract valued at $1,183.60. The order, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a routine pharmaceutical procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed this delivery order from its corporate...
- The Defense Logistics Agency awarded a $2,148.59 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Lyrica 225 mg capsules (90-count). This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 29, 2025, with performance to take place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ4Y3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,206.28 to AmerisourceBergen Drug Corp for the supply of Lyrica 225 mg capsules (90-count units). This firm fixed-price contract, awarded on September 27, 2025, represents a non-competitive, non-set-aside procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery order has an ultimate completion date of September 29, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's comprehensive pharmaceutical prime vendor agreement with DLA valued at $999.99 million through December 2026. The IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical commodities to support military healthcare operations worldwide. Lyrica, a neurological treatment used for pain management and neuropathic conditions, aligns with the extensive therapeutic portfolio AmerisourceBergen maintains under its DLA contract, which encompasses specialty medications, brand-name and generic pharmaceuticals, vaccines, and medical supplies for the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/27/25 |